Group 1 - Philip Morris International Inc. held its Q2 2025 earnings call on July 22, 2025, with key participants including CFO Emmanuel Babeau and VP of Investor Relations James R. Bushnell [1][2] - The company released detailed information regarding its Q2 2025 results, which is accessible on its website [3] - A glossary of terms and reconciliations for non-GAAP financial measures is available in the company's Form 8-K and on the Investor Relations website [4]

Group 1 - The article emphasizes the advantages of a dividend-focused value investment strategy, highlighting capital preservation and steady income growth as key benefits [1] - The author discusses a diversified dividend stock portfolio that prioritizes high-quality value stocks, which are expected to provide meaningful growth and long-term safety [1] Group 2 - The author has disclosed a beneficial long position in the shares of PM and PG, indicating a personal investment interest in these companies [2] - The article is presented as a personal opinion and does not constitute investment or tax advice, emphasizing the author's status as a private investor [3]

Jacek Olczak, Philip Morris International CEO, joins 'Money Movers' to discuss q2 earnings and smoke-free products. ...

Core Insights - Philip Morris International Inc. (PM) reported strong second-quarter 2025 results, with both net sales and earnings increasing year over year, although net sales missed the Zacks Consensus Estimate while earnings exceeded it [1][10] - The company has raised its full-year guidance reflecting robust momentum across regions and product categories, particularly in smoke-free products like IQOS and ZYN [1][10] Financial Performance - Adjusted earnings per share (EPS) for the second quarter were $1.91, a 20.1% increase year over year, beating the Zacks Consensus Estimate of $1.85 [2][10] - Net revenues reached $10,140 million, a 7.1% increase on a reported basis and 6.8% on an organic basis, but fell short of the Zacks Consensus Estimate of $10,255 million [3][10] - Adjusted operating income rose 16.1% to $4,246 million, driven by improved pricing and positive volume/mix, despite increased costs in marketing and administration [6][10] Product Performance - Revenues from smoke-free products increased 15.2%, accounting for 41% of total revenues, with strong performance in both IQOS and ZYN [5][10] - Net revenues from combustible products grew 2.1% year over year, supported by strong pricing despite expected volume declines [4][10] Regional Performance - European region net revenues grew 8.7% to $4,234 million, driven by positive pricing and volume mix, although total shipment volumes decreased [8][10] - In the Americas, revenues rose 12.7% to $1,272 million, primarily due to nicotine pouch sales, with total shipment volumes increasing [11][10] - The SSEA, CIS & MEA regions saw net revenues increase by 5.6% to $2,926 million, while the EA, AU & PMI GTR regions grew 2.1% to $1,708 million [8][9] Future Outlook - For 2025, adjusted EPS is now projected in the range of $7.43-$7.56, indicating 13-15% growth, up from the previous range of $7.36-$7.49 [13][10] - PM expects net revenues to increase 6-8% on an organic basis and operating income to rise 11-12.5% [15][10] - The company anticipates operating cash flow exceeding $11.5 billion in 2025, with capital expenditures around $1.6 billion to support smoke-free business investments [15][10]

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive has bureaus and studios in key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2] Group 2 - The company is focused on sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] - Proactive adopts technology to enhance workflows and improve content production [4] - Automation and software tools, including generative AI, are used, but all content is edited and authored by humans [5]

Core Insights - Philip Morris reported $10.14 billion in revenue for Q2 2025, a year-over-year increase of 7.1%, with an EPS of $1.91 compared to $1.59 a year ago, indicating positive growth despite a slight revenue miss against estimates [1] - The company’s revenue fell short of the Zacks Consensus Estimate by 1.12%, while the EPS exceeded the consensus estimate by 3.24% [1] Financial Performance - Shipment Volume for Cigarettes and HTUs totaled 194.06 billion, slightly below the average estimate of 195.25 billion [4] - Shipment Volume for EA, AU & PMI DF was 28.33 billion, surpassing the average estimate of 27.1 billion [4] - Shipment Volume for SSEA, CIS & MEA reached 95.33 billion, close to the average estimate of 95.56 billion [4] - Shipment Volume for Americas was 15.33 billion, below the average estimate of 16.46 billion [4] Geographic Revenue Breakdown - Net Revenues for EA, AU & PMI DF were $1.71 billion, slightly below the average estimate of $1.77 billion, reflecting a year-over-year change of +2.1% [4] - Net Revenues for Europe amounted to $4.23 billion, slightly below the estimated $4.26 billion, with a year-over-year increase of +11% [4] - Net Revenues for SSEA, CIS & MEA were $2.93 billion, matching the average estimate, with a year-over-year change of +5.6% [4] - Net Revenues for Americas were $1.27 billion, below the average estimate of $1.33 billion, showing a year-over-year change of +12.7% [4] Smoke-Free and Combustible Tobacco Revenue - Net Revenues from Smoke-Free Excl. W&H in SSEA, CIS & MEA were $365 million, below the average estimate of $398.54 million, with a year-over-year change of +7.7% [4] - Net Revenues from Smoke-Free Excl. W&H in EA, AU & PMI DF were $1.05 billion, slightly below the estimated $1.07 billion, reflecting a -0.2% change year-over-year [4] - Total Net Revenues from Smoke-Free Excl. W&H were $4.1 billion, below the average estimate of $4.23 billion, with a year-over-year increase of +16.3% [4] - Total Net Revenues from Combustible Tobacco were $5.98 billion, below the average estimate of $6.08 billion, with a year-over-year change of +2.1% [4] Stock Performance - Philip Morris shares have returned -2.4% over the past month, contrasting with the Zacks S&P 500 composite's +5.9% change, indicating underperformance relative to the broader market [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential for outperformance in the near term [3]

Financial Data and Key Metrics Changes - The company reported record net revenues of $4 billion from its smoke-free portfolio in Q2 2025, contributing to strong double-digit adjusted diluted EPS growth in both constant currency and dollar terms [6][10] - Q2 shipment volume growth was 1.2%, with organic top-line growth of 6.8%, reaching over $10 billion in quarterly net revenues for the first time [10][11] - Adjusted diluted EPS increased by 20% to $1.91, reflecting strong top-line momentum and positive margin evolution [11][12] Business Line Data and Key Metrics Changes - The smoke-free business saw a 13% growth in shipment volumes, with heated tobacco unit (HTU) shipment volume growing by 9.2% to 38.8 billion units in Q2 [12][16] - ZYN experienced a significant acceleration in U.S. consumer offtake growth, reaching 26% for Q2 and 36% in June [7][35] - E-vapor shipments more than doubled year-on-year, contributing to gross margin expansion [8][16] Market Data and Key Metrics Changes - In Europe, the smoke-free product market is recovering from the characterizing flavor ban, with notable growth in Italy and other markets [7][25] - The U.S. market for ZYN is showing strong recovery, with shipments increasing by 41% year-on-year [36][37] - Combustible net revenues increased by 2.9%, with robust pricing contributing to gross profit growth despite volume declines [17][41] Company Strategy and Development Direction - The company is focused on maximizing the growth of its smoke-free products, particularly IQOS, ZYN, and VIVE, while maintaining a resilient combustible business model [24][48] - Continuous innovation in devices and consumables is a key pillar for growth, with the rollout of Illumi Eye technology and new product variants [25][30] - The company aims to achieve a fifth consecutive year of total volume growth, driven by its smoke-free portfolio [15][42] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong fundamentals of the business, raising the adjusted diluted EPS full-year forecast to 13% to 15% growth [10][42] - The company anticipates continued strong momentum in smoke-free products, while acknowledging potential challenges in combustible volumes [14][88] - Management highlighted the importance of addressing the illicit trade issue in the EU, which poses a risk to market growth [24][64] Other Important Information - The company achieved over $500 million in gross cost savings year-to-date through efficiency initiatives [20] - The regulatory environment is seen as a key enabler for smoke-free growth, with positive developments in several markets [22][24] - The company is on track to meet its three-year CAGR targets, demonstrating strong financial performance across all categories [46][48] Q&A Session Summary Question: ZYN restocking and future growth expectations - Management acknowledged that restocking was lower than expected but emphasized the strong momentum in ZYN's growth, with June showing 36% consumer offtake growth [53][60] Question: EU tax proposals and updates - Management refrained from elaborating on specific tax proposals, noting that the process is in its early stages and requires further clarity [62][64] Question: IQOS ILUMA U.S. approval timing - Management remains hopeful for a second-half approval but acknowledged the heavy workload at the FDA, which could delay the timeline [71][73] Question: Combustible volume expectations - Management confirmed a target of around a 2% decline in combustible volumes for the year, aligning with long-term trends [77][78] Question: Increase in underlying guidance - Management indicated that the second half is expected to align with previous expectations, despite some phasing and comparison dynamics affecting performance [83][90]

Financial Data and Key Metrics Changes - The company reported record net revenues of $4 billion from its smoke-free portfolio, contributing to strong double-digit adjusted diluted earnings per share growth in both constant currency and dollar terms [6][10]. - Adjusted diluted EPS reached $1.91, reflecting a growth of 20%, with a favorable currency variance impacting the results [11][12]. - Total shipment volumes grew by 2.5% in H1, with organic net revenues increasing by 8.4% [11][12]. Business Line Data and Key Metrics Changes - The smoke-free business saw a 13% growth in shipment volumes, with heated tobacco unit (HTU) shipment volume growing by 9.2% in Q2 [12][15]. - ZYN experienced a significant acceleration in U.S. consumer offtake growth, reaching 26% in Q2 and 36% in June [7][34]. - E-vapor shipments more than doubled year-on-year, contributing to gross margin expansion [8][16]. Market Data and Key Metrics Changes - In Europe, the smoke-free business showed broad-based growth, particularly in Italy, as the impact of the flavor ban receded [7][25]. - The U.S. market for ZYN saw a recovery in offtake growth, with shipments increasing by 41% year-on-year [34][35]. - The international market for nicotine pouches grew by 65%, nearly tripling outside the Nordics [7][27]. Company Strategy and Development Direction - The company aims to maximize the growth of IQOS while expanding the presence of ZYN and VIVE under its multi-category strategy [24][25]. - Continued investment in smoke-free brands is prioritized, with a focus on expanding production capacity and market access [21][23]. - The company is committed to addressing the regulatory environment to support smoke-free growth, particularly in the EU [24][62]. Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong momentum of smoke-free products continuing into H2, despite expected modest declines in combustible volumes [10][15]. - The company raised its adjusted diluted EPS full-year forecast to a growth range of 13% to 15% [10][42]. - Management acknowledged the challenges posed by the illicit trade and regulatory changes but remains optimistic about the overall growth trajectory [24][46]. Other Important Information - The company achieved over $500 million in gross cost savings year-to-date through efficiency initiatives [21]. - The smoke-free user base grew by approximately 5 million, reaching around 41.5 million as of June 30 [22]. - The company is on track to meet its three-year CAGR targets, demonstrating strong financial growth [46]. Q&A Session Summary Question: Regarding ZYN's restocking and future growth expectations - Management clarified that the restocking was slightly lower than expected, but emphasized the strong momentum in ZYN's growth, with June showing a 36% increase in consumer offtake [52][58]. Question: Update on EU Tobacco Excise Directive proposals - Management noted that the initial proposal includes differentiation between smoke-free and combustible products regarding minimum taxation, but further clarity will be provided as the legislative process unfolds [62][64]. Question: Timing for IQOS ILUMA U.S. approval - Management remains hopeful for a second-half approval but acknowledged the heavy workload at the FDA, which could delay the timeline [70][72]. Question: Drivers of IQOS reacceleration and sustainability - Management highlighted the waning effects of the flavor ban in Europe and strong performance in markets like Japan and global travel retail as key drivers for IQOS growth [72][74]. Question: Combustible volume expectations - Management confirmed a target of around a 2% decline in combustible volumes for the year, aligning with long-term trends [76][78]. Question: Increase in underlying guidance and second-half considerations - Management explained that the second half is expected to maintain strong momentum in smoke-free products, despite anticipated declines in combustibles [81][85].

What's Next for Philip Morris? While Philip Morris has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Philip Morris (PM) came out with quarterly earni ...

Financial Performance - The company experienced strong growth in Q2 2025, with adjusted diluted EPS up by 201%[7] - Adjusted operating income increased by 161%[7] and net revenues grew by 68%[7] - For H1 2025, adjusted diluted EPS increased by 161%[8], adjusted operating income by 145%[8], and net revenues by 65%[8] - The company is raising its 2025 forecast to 13-15% adjusted diluted EPS growth[6] Smoke-Free Products (SFP) - Smoke-free products are driving total volume growth[10], with H1 2025 shipment volume increasing by 131%[10] - Smoke-free net revenues and gross profit showed organic growth of 270%[11] and 154%[11] respectively in H1 2025 - The company's multicategory strategy is catalyzing SFP user growth to over 41 million[17] - IQOS quarterly net revenues are over $3 billion[19] ZYN (Nicotine Pouches) - ZYN nicotine pouch shipment volumes increased by 43%[22] in Q2 2025 compared to the previous year - U S ZYN volumes increased by 41%[22] and international volumes excluding Nordics increased by 179%[22] - The company expects strong H2 offtake growth for ZYN as retail availability normalizes[31] Regional Performance - Europe experienced a 135%[25] growth in IQOS, ZYN & VEEV shipment in Q2 2025 - In Japan, the company's HTU adjusted IMS grew by 78%[26] in Q2 2025, with a 48%[26] HnB offtake category share - The company is seeing excellent IQOS key city progress across global markets[34]